Results 181 to 190 of about 125,449 (211)

Antiviral activity and pharmacokinetics of HOE 602, an acyclic nucleoside, in animal models

Antiviral Research, 1990
I Winkler, Irvin Winkler
exaly  

Antagonism of kinin effects on epithelia by Hoe 140: apparently competitive and non-competitive interactions

British Journal of Pharmacology, 1992
L J Macvinish, A W Cuthbert, A W Cuthbert   +2 more
exaly  

Dose-Dependent Reduction of Myocardial Infarct Mass in Rabbits by the NHE-1 Inhibitor Cariporide (HOE 642)

Clinical and Experimental Hypertension, 1998
Wolfgang Linz, A Weichert, U Albus
exaly  

Inhibition of rats adjuvant arthritis by a bradykinin antagonist hoe 140 and its influence on kallikreins

General Pharmacology, 1996
K J Wirth, J N Sharma, Jagdish N Sharma
exaly  

Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects

European Journal of Clinical Pharmacology, 1984
P Hajdu, H Metzger
exaly  

Characterization of the bradykinin receptor in the human nasal airway using the binding of [125I]-Hoe 140

British Journal of Pharmacology, 1996
Glenis Scadding, J C Foreman, K Wirth
exaly  

The herbicidally active experimental compound Hoe 704 is a potent inhibitor of the enzyme acetolactate reductoisomerase

FEBS Letters, 1988
Arno Schulz
exaly  

HOE! HOE! HOE!

openaire   +1 more source

Inhibitory effects of Hoe 140 on vasodilator responses to bradykinin in the mesenteric vascular bed of the cat

European Journal of Pharmacology, 1993
J A Santiago, P J Kadowitz, Philip J Kadowitz   +2 more
exaly  

Effects of HOE 694 — a novel inhibitor of Na/H exchange — on NIH 3T3 fibroblasts expressing the oncogene

European Journal of Pharmacology, 1993
Markus Ritter, Florian Lang, Ewald Wöll
exaly